Adherence to current vaccination recommendations for patients with rheumatoid arthritis in Mexico

Patients with RA have a two to four-fold increased risk of developing infections compared to the general population. For this reason, the administration of influenza, pneumococcal and shingles vaccines is recommended for all patients with RA, preferably prior to initiating treatment, Previous studie...

Full description

Saved in:
Bibliographic Details
Published in:Reumatología clinica (Barcelona) 2021-03, Vol.17 (3), p.155-159
Main Authors: Cepeda-Perez, Andrea Sofia, Tello Winniczuk, Nina, Diaz-Borjon, Alejandro
Format: Article
Language:English
Subjects:
Arthritis
Artritis
Guidelines
Guías
Immunization
Inmunización
Reumatoide
Rheumatoid
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with RA have a two to four-fold increased risk of developing infections compared to the general population. For this reason, the administration of influenza, pneumococcal and shingles vaccines is recommended for all patients with RA, preferably prior to initiating treatment, Previous studies have demonstrated the low prevalence of vaccination as well as adherence to current recommendations by rheumatologists in other regions. To determine the knowledge and adherence to the current vaccination recommendations for patients with RA by rheumatology members of the Mexican College of Rheumatology (MCR), and to identify barriers to their application in this population. A cross-sectional study was conducted through a survey sent to 577 rheumatologists from Mexico in January 2017. We received completed surveys from 122 individuals, representing 21.14% of the 577 rheumatologists in our registry. Fifty percent responded that they recommended immunisation against influenza to 76%–100% of their patients, 36.07% recommended immunisation against pneumococcus to 76%–100% of their patients, and 69.67% of the survey responders did not recommend shingles immunisation routinely to their patients. The data collected in this study show there is poor adherence to immunisation schedules recommended for the RA population. This data suggests there is misinformation about the effectiveness, safety and optimal timing of immunisation in patients with RA in Mexico. Los pacientes con artritis reumatoide (AR) presentan un incremento de dos a cuatro veces del riesgo de infecciones comparado con la población general. Por esta razón, existen recomendaciones sobre la aplicación de vacunas de influenza, neumococo y herpes zóster en todos los pacientes con AR, previo al inicio del tratamiento. Varios estudios han demostrado la baja prevalencia de vacunación así como la adherencia a las recomendaciones actuales de inmunización por los reumatólogos. El objetivo de este estudio fue determinar el conocimiento de las recomendaciones actuales de inmunización en pacientes con AR por los reumatólogos miembros del Colegio Mexicano de Reumatología (CMR), así como identificar las barreras en su aplicación en dicha población. Se realizó un estudio transversal por medio de una encuesta a 577 reumatólogos de México en enero 2017. Se obtuvieron 122 respuestas, representando el 21,14% de los 577 reumatólogos. El 50,82% respondió que recomendaba al 76%–100% de sus pacientes la vacuna de influenza, el
ISSN:2173-5743
2173-5743
DOI:10.1016/j.reumae.2019.04.004